Prevalence and Risk Factors For Genital Human Papillomavirus Infections Among Women In Southwest Nigeria

  • Yewande T Nejo
  • David O Olaleye
  • Georgina Njideka Odaibo


There is a great variation in the prevalence of cervical HPV infection worldwide with some of the highest rates being found in African women. Early onset of sexual activity (≤ 15 age), multiparity and sexual promiscuity have been recognized as some of the significant risk factors for HPV infection. In Nigeria, there is scarcity of data on the degree of relationship between these factors and the prevalence of HPV infection. Thus, this study was designed to determine the prevalence of genital HPV infection with its potential risk factors among women in Southwest Nigeria. Cervical swab specimen was collectedfrom 295 consenting women including those for routine cervical cancer screening, STI clinic attendees and women who attended community based outreach programmes. Viral DNA was extracted from the swab samples using commercially available DNA extraction Kit and amplified by PCR using two set of consensus primers (PGMY09/11 and degenerate GP-E6/E7). Fifty five samples were positive to HPV DNA giving a prevalence of 18.6%.Risk factors such as lack of formal education (P-value: 0.003), divorcee (P-value: 0.019), polygamy(P-value: 0.027), unemployment (P-value: 0.023), low income earnings (P-value: 0.018), younger age (<18years)at sexual debut (P-value: 0.039) and passive smoking (P-value: 0.017) were significantly associated with HPV infection.High HPV prevalenceand associated risk factorsobserved in this study shows the continuous transmission of the virus in Southwest Nigeria. Hence,enlarged monitoring including intensepublic awareness and cervical cancer screening is urgently needed for prevention and control strategies


Akarolo-Anthony, S. N., A. O.Famooto, E. O.Dareng, O. B. Olaniyan, R.Offiong, C. M. Wheeler, and C. A. Adebamowo. 2014. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health, 14(1), 656. 1471-2458-14-656
Allan, B., D. J.Marais, M.Hoffman, S.Shapiro, and A.L. Williamson. 2008. Cervical human papillomavirus (HPV) infection in South African women: Implications for HPV screening and vaccine strategies. Journal of Clinical Microbiology 46, 740–742. doi:10.1128/JCM.01981-07
Aral, S. O., and K. K. Holmes.2008. The epidemiology of STIs and their social and behavioural determinants: industrialized and developing countries. In: Holmes, K. K., Sparling, P. F., Stamm, W. E., Piot, P., Wasserheit, J. N., Corey, L., Cohen, M. S., Watts, D. H. eds. Sexually Transmitted Diseases. 4th ed. New York: McGraw-Hill; 2008: 53-92.
Baloch, Z., T.Yuan, S.Yindi, Y.Feng, W.Tai, Y.Liu, L. Liu, A.Zhang, B.Wang, X.Wu, and X.Xia, 2016. Prevalence of genital human papillomavirus among rural and urban populations in southern Yunnan province, China.Brazilian Journal of Medical and Biological Research 49, 1–7. doi:10.1590/1414-431X20165254
Bayo S., F. X. Bosch, Sanjosé, N. Muñoz, A. L. Combita, P. Coursaget, M. Diaz, A. Dolo, A. J. van den Brule, andC. J. Meijer.2002. Risk factors of invasive cervical cancer in Mali. International Journal Epidemiology31(1):202–209.
Borena, W., M.Grünberger, A.Widschwendter, K. H.Kraxner, E.Marth, P.Mayr, and D. Holm-von Laer.2016. Pre-vaccine era cervical Human papillomavirus infection among screening population of women in west Austria. BMC Public Health, 16(1),889. s12889-016-3581-0
Boumba, L. M. A., S. Z.Assoumou, L.Hilali, J. V. Mambou, D. Moukassa, and M. M.Ennaji. 2015. Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates. Infectious Agents and Cancer, 10(1),15. 10.1186/s13027-015-0010-4
Bruni, L., L.Barrionuevo-Rosas,G.Albero,B. Serrano,M.Mena,Z.Gomez,J.Muñoz,F. X.Bosch,and S. 2016. Human Papillomavirus and related diseases report, ICO Information Centre on HPV and Cancer (HPV Information Centre).
Bruni, L., L.Barrionuevo-Rosas, G.Albero, M.Aldea, B.Serrano, S.Valencia, M. Brotons, M. Mena, R.Cosano, J.Muñoz, F. X.Bosch, Sanjosé, and X. Castellsagué. 2015. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Nigeria: Summary Report 2015-12-23. [Data Accessed
Burchell, A.N., R. L.Winer, Sanjosé, and E. L.Franco. 2006. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 24. doi:10.1016/j.vaccine.2006.05.031
Cao, S., C.Yang, Y.Gan, and Lu, Z. 2015."The Health Effects of Passive Smoking: An Overview of Systematic Reviews Based on Observational Epidemiological Evidence.".PloS One.10(10): e0139907. doi:10.1371/journal.pone. 0139907. PMC 4595077 .PMID 26440943.
Castellsague, X., C.Menendez, M. P.Loscertales, J. R.Kornegay, F.dos Santos, F. X.Gomez-Olive, B.Lloveras, N.Abarca, N.Vaz, A.Barreto, F. X.Bosch, and P. Alonso.2001. Human papillomavirus genotypes in rural Mozambique. Lancet, 358:1429–1430.
Castle, P. E., M.Schiffman, R.Herrero, A. Hildesheim, A. C. Rodriguez,M. C.Bratti,M. E. Sherman,S.Wacholder,R.Tarone,and R. D.Burk.2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis; 191:1808–1816.
Centers for Disease Control and Prevention.2013. STD curruculum for clinical educators “Genital Human papillomavirus” (pp. 1–37).
Centers for Disease Control and Prevention. 2015.Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention June 12.
Clarke, M. A., J. C.Gage, K. O.Ajenifuja, N. A.Wentzensen, A. C.Adepiti, S.Wacholder, R. D.Burk, and M. Schiffman.2011. A population-based, cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infect Agent Cancer, 6:12.
Collins, S. I., S. Mazloomzadeh, H. Winter, T. P. Rollason, P. Blomfield, L. S. Young, and C. B. J. Woodman, C. 2005. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: A longitudinal study. International Journal of Cancer114.3: 498–500.
Das, B. C., V.Gopalkrishna, S.Hedau, and S. Katiyar.2000. Cancer of the uterine cervix and human papillomavirus infection. CURRENT SCIENCE, 2000; Vol. 78, No.1,10
de Sanjosé, S., M.Diaz, X.Castellsagué, G.Clifford, L.Bruni, N.Muñoz, and F. X. Bosch. 2007.Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis.7(7):453 59.
De Vuyst, H., S. Steyaert, L.Van Renterghem, P.Claeys, L.Muchiri, S.Sitati, S.Vansteelandt, W.Quint, B.Kleter, E.Van Marck, and M. Temmerman.2003. Distribution of human papillomavirus in a family planning population in nairobi, kenya. Sex Transm Dis, 30:137–142.
Denny, L., I.Adewole, R.Anorlu, G.Dreyer, M.Moodley, T.Smith, L.Snyman, E. Wiredu, A.Molijn, W.Quint, G. Ramakrishnan, and J. Schmidt. 2014. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int. J. Cancer,134: 1389–1398. doi:10.1002/ijc.28425
Esere, M. O. 2008.Effect of sex education programme on at-risk sexual behavior of school-going adolescents in Ilorin Nigeria.Afr Health Sci. 8(2): 120-125. PubMed | Google Scholar
Fadahunsi, O. O., G. O.Omoniyi-Esan, A. A.Banjo, O. A.Esimai, D.Osiagwu, F.Clement, O. V.Adeteye, R. A. Bejide, and S. 1. Iyiola.2013. Prevalence of High Risk oncogenic HPV types in cervical smears of women attending well women clinic in Ile-Ife. Gynaecol Obstet.3(6):1000185. PubMed | Google Scholar
Fonseca, A. J., D.Taeko, T. A.Chaves, L. D. C.Amorim, R. S. W.Murari, A. E.Miranda, Z. Chen, R. D.Burk, and L. C. L. Ferreira.2015. HPV Infection and Cervical Screening in Socially Isolated Indigenous Women Inhabitants of the Amazonian Rainforest. PLoS ONE 10(7): e0133635. doi:10.1371/journal.pone.0133635
Gage, J.C., K. O.Ajenifuja, N. Wentzensen, A. C.Adepiti, M.Stoler, P. S.Eder, L.Bell, N.Shrestha, C.Eklund, M.Reilly, M.Hutchinson, S.Wacholder, P. E.Castle, R. D. Burk, and M. Schiffman. 2013. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. International Journal of Cancer, doi:10.1002/ijc.27563
Herrero, R., A. C.Hildesheim,M. E.Bratti,M.Sherman,J.Hutchinson,I. Morales,M. Balmaceda, D.Greenberg, M.Alfaro,R. D.Burk,S.Wacholder,M.Plummer,and M.Schiffman. 2000. Population-based study of humanpapillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst92:464–74.
Idso, C. 2009. Sexually transmitted infection prevention in newly single older women: a forgotten health promotion need. Journal for Nurse Practitioners, 5(6):440–6.
Jiang, Y., P.Brassard, A.Severini, Y.Mao, Y.Li, J.Laroche, S.Chatwood, A. Corriveau, K.Kandola, B.Hanley, I.Sobol, M.Ar-Rushdi, G.Johnson, J.Lo, S.Ratnam, T.Wong, A.Demers, G.Jayaraman, S.Totten, andH.Morrison. 2013. The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada. Infectious Agents and Cancer, 8, 25.doi:10.1186/1750-9378-8-25
Kahn, J. A., S. L. Rosenthal, P. A. Succop, G. Y. Ho, and R. D. Burk.2002a. Mediators of the association between age of first sexual intercourse and subsequent Human papillomavirus infection.Paediatrics 109.1:E5.
Kahn, J. A., S. L. Rosenthal, P. A. Succop, G. Y. Ho, and R. D. Burk. 2002b. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women Journal of Paediatrics 141.5:718–723.
Keita, N., G. M.Clifford, M. Koulibaly, K.Douno, I.Kabba, M.Haba, and S. Franceschi. 2009. HPV infection in women with and without cervical cancer in Conakry, Guinea. British Journal of Cancer, 101(1), 202–208.
Kennedy, N.T., D.Ikechukwu, and B. Goddy. 2016. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria. The Pan African medical journal 23, 85. doi:10.11604/pamj.2016. 23.85.8510
Koutsky, L. A. and N. B. Kiviat. 1999. Genital human papillomavirus. In: Holmes, K. K., P-A.Mardh, P. F. Sparling, et al., editors. Sexually transmitted diseases. New York: McGraw-Hill; p. 347–59.
Kuhn, L., L.Denny, A.Pollack, A.Lorincz, R. M.Richart, and T. C.Wright. 2000. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst.92:818–825.
Lazcano-Ponce, E., R.Herrero, N.Munoz, A.Cruz, K. V.Shah, P.Alonso, P.Hernandez, J.Salmeron, andM. Hernandez. 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer91:412–20.
Meloni, A., R.Pilia, M.Campagna, A.Usai, G.Masia, V.Caredda, and R.C. Coppola. 2014. Prevalence and molecular epidemiology of human papillomavirus infection in Italian women with cervical cytological abnormalities. Journal of Public Health Research 3.doi:10.4081/jphr.2014.157.
Ngabo, F., S.Franceschi, I.Baussano, M. C.Umulisa, P. J. F. Snijders, A. M. Uyterlinde, F.Lazzarato, V. Tenet, M.Gatera, A.Binagwaho, and M. G. Clifford. 2016. Human papillomavirus infection in Rwandaat the moment of implementation of a national HPV vaccination programme. BMC Infectious Diseases(2016) 16:225 DOI 10.1186/s12879-016-1539-6
Nweke, I. G., A. A. F.Banjo, F. B.Abdulkareem, and V. U. Nwadike.2013. Prevalence of Human Papilloma virus DNA in HIV positive women in Lagos University Teaching Hospital (LUTH) Lagos, Nigeria. British Microbiology Research Journal. New Delhi. Retrieved from
Oriel, J. D. 1971.Natural history of genital warts.Br J Vener Dis47(1):1–13.
Partridge, J. M., and L. A. Koutsky. 2006. Genital human papillomavirus infection in men. Lancet Infect Dis6(1):21–31.
Piras, F., M.Piga, A.De Montis, A. R.Zannou, L.Minerba, M.T. Perra, D.Murtas, M.Atzori, M.Pittau, C.Maxia, and P. Sirigu. 2011. Prevalence of human papillomavirus infection in women in Benin, West Africa. Virology Journal 8, 514.doi:10.1186/1743-422X-8-514
Rousseau, M. C., M. Abrahamowicz, L. L. Villa, M. C. Costa, E. Thomas, T. E. Rohan, E. L. Franco. 2003. Predictors of Cervical Co-infection with Multiple Human Papillomavirus Types. Cancer Epidemiology, Biomarkers & Prevention12(10):1029–1037
Salih, M. M., M. E.Safi, K.Hart, K.Tobi, and I. Adam. 2010. Genotypes of human papilloma virus in Sudanese women with cervical pathology. Infectious Agents and Cancer, 5, 26.
Samoff, E., E. H. Koumans,L. E. Markowitz,M.Sternberg,M. K.Sawyer,D. Swan,J. R.Papp,C. M.Black,and E. R.Unger.2005. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol162(7):668–75.
Sarma, U., J.Mahanta, B. J.Borkakoty, K. L.Talukdar, R. Gogoi, and K. Yadav. 2013. Demographic Characteristic of HPV Infection in Women - A Hospital Based Study from Guwahati, India. National Journal of Medical Research, 3 (1), 1-4.
Schnatz, P. F., N. V.Markelova, D.Holmes, S. R.Mandavilli, and D. M. O’Sullivan. 2008. The prevalence of cervical HPV and cytological abnormalities in association with reproductive factors of rural Nigerian women. J Womens Health (Larchmt) 17: 279-285.
Serwadda, D., M. J.Wawer, K. V.Shah, N. K.Sewankambo, R.Daniel, C.Li, A.Lorincz, M. P.Meehan, F.Wabwire-Mangen, and R. H.Gray. 1999. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis,180:1316–1319.
Smith, J. S., A.Melendy, R. K.Rana, and J. M. Pimenta. 2008. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health,43:S5–S25. S25 e21-41.
Sotlar, K., D.Diemer, A.Dethleffs, Y.Hack, A.Stubner, N.Vollmer, and B. Bültmann. 2004. Detection and typing of human papillomavirus by E6 nested multiplex PCR. Journal of Clinical Microbiology, 42(7), 3176–3184.
Sotlar, K., D.Diemer, A.Dethleffs, Y.Hack, A.Stubner, N.Vollmer, S.Menton, M.Menton, K.Dietz, D.Wallwiener, R.Kandolf, and B.Bültmann. 2004. Detection and typing of human papillomavirus by E6 nested multiplex PCR. Journal of Clinical Microbiology 42, 3176–3184. doi:10.1128/JCM.42.7.3176-3184.2004
Temmerman, M., M. W.Tyndall, N.Kidula, P.Claeys, L.Muchiri, and W. Quint. 1999. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J GynaecolObstet, 65:171–181.
Thomas, J. O., R.Herrero, A. A.Omigbodun, K.Ojemakinde, I. O.Ajayi, A.Fawole, O. Oladepo, J. S.Smith, A.Arslan, N.Munoz, P. J.Snijders, C. J.Meijer, S. Franceschi. 2004. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer90: 638–645
Traore, I. M. A., T. M.Zohoncon, A.Dembele, F. W.Djigma, D.Obiri-Yeboah, G.Traore, and J. Simpore. 2016. Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso. BioMed Research International, 2016, 7092583.
Vaccarella,S.,R.Herrero, P. J. F.Snijders, M. Dai, J. O. Thomas, N. T.C.Hieu,E.Ferreccio,H. Matos, S.Posso, H. R. de Sanjosé, S. Shin,E.Sukvirach,N.Lazcano-Ponce,C. J. Muñoz, L. M. Meijer,S.Franceschi, andthe IARC HPV Prevalence Surveys (IHPS) Study Group. 2008. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol; 37:536–46. [PubMed: 18316350]
Vinodhini, K., S.Shanmughapriya, B. C.Das, and K. Natarajaseenivasan. 2012. Prevalence and risk factors of HPV infection among women from various provinces of the world. Archives of Gynecol Obstet. 2012; 285(3):771-7.
Walboomers, J. M. M., M. V.Jacobs, M. M.Manos, F. X.Bosch, J. A.Kummer, K. V.Shah, P. J.Snijders, J.Peto, C. J. Meijer, and N. Muñoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol.189:12-19. PubMed Abstract | Publisher Full Text
Wiley, D. J., E.Wiesmeier,E.Masongsong,K. H.Gylys,L. A.Koutsky,D. G.Ferris,E.Barr,and R. J.Yu.2006. Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection. Cancer Epidemiol Biomarkers Prev; 15:915–20. [PubMed: 16702370]
Winder, D.M., S.L. Ball, K.Vaughan, N.Hanna, Y. L.Woo, J. T.Fränzer, J. C.Sterling, M. A.Stanley, H.Sudhoff, P. K.Goon. 2009. Sensitive HPV detection in oropharyngeal cancers. BMC Cancer 9, 440.doi:10.1186/1471-2407-9-440
Winer, R. L., andL. A. Koutsky. 2004. The epidemiology of human papillomavirus infections. InCervical cancer: from etiology to prevention. Dordrecht, T.Rohan, and K.Shah, editors. The Netherlands: Kluwer Academic Publishers; p. 143–87.
Woodman, C. B. J., I.Stuart, S. I. Collins, and L. S. Young. 2007. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer7:11-22. PubMed Abstract | Publisher Full Text
Xi, L. F., P.Toure, C. W.Critchlow, S. E.Hawes, B.Dembele, P. S.Sow, andN. B. Kiviat. 2003. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer, 103:803–809.
Yang, L., S.Xie, X.Feng, Y.Chen, T.Zheng, M.Dai, C. K.Zhou, Z.Hu, N.Li, and D.Hang. 2015. Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis. Nature Publishing Group 1–10. doi:10.1038/srep14667
Zheng, Z. M., and C. C. Baker.2006. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci. 11(1):2286–2302.
zurHausen, H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst; 3(92(9)):690–8. doi: 10.1093/jnci/92.9.690.
Section C (Clinical and Laboratory Research)